| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Technical Officer | SVP, Chief Technical Officer
1 company
Labarre Michael J. is a SVP, Chief Technical Officer at HALOZYME THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 28 sells.
Estimated insider holdings value: $12.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 21,697 | $58.10 | $1,260,680.74 | -2.0% | -5.7% | +20.5% | |
| Oct 16, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $53.50 | $1,070,058.65 | -3.7% | +0.7% | +25.1% | |
| Sep 18, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $62.45 | $1,249,095.53 | -3.7% | -22.0% | +23.1% | |
| Aug 21, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $61.40 | $1,228,019.90 | -3.8% | -27.9% | +15.2% | |
| Jul 24, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $55.00 | $1,100,023.38 | -3.8% | -6.5% | +6.6% | |
| Jun 18, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 10,000 | $49.43 | $494,260.00 | -5.6% | +25.1% | +5.7% | |
| May 22, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $45.27 | $905,480.00 | -5.6% | +34.0% | +18.2% | |
| Apr 17, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $38.42 | $768,390.00 | -5.6% | +44.9% | +54.6% | |
| Mar 13, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $41.96 | $839,100.00 | -6.0% | +20.7% | +47.7% | |
| Feb 28, 2024 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 20,000 | $39.75 | $794,922.99 | -4.1% | +8.5% | +45.4% |